Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice

Journal of Investigative Dermatology

Volumn 112, Issue 6, 1999, Pages 965-970

  Miyauchi Hashimoto, Hiroko ^b   Okamoto, Hiroyuki ^b   Tanaka, Kiyoji ^a   Horio, Takeshi ^b  

^a OSAKA UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunosuppression; Tumor immunity

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA DAMAGE; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN CARCINOMA; ULTRAVIOLET B RADIATION; XERODERMA PIGMENTOSUM;

EID: 0033039248     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00597.x     Document Type: Article

References (35)

1. Aboussekhra A, Wood RD; Repair of UV-damaged DNA by mammalian cells and Saccharomyces cerevisiae. Curr Opin Genet Dev 4:212-220, 1994
2. Anstey AV, Arlett CF, Cole J, et al: Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Br J Dermatol 125:272-278, 1991
3. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ. Nucleotide excision repair syndrome: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds). The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998:245-274
4. Cleaver JE: Defective repair replication of DNA in xeroderma pigmentosum. Nature 218:652-656, 1968
5. Dupuy JM, Lafforet D: A defect of cellular immunity in xeroderma pigmentosum. Clin Immunol Immunopathol 3:52-58, 1974
6. Elmets CA, Larson K, Urda GA, Schacter B: Inhibition of postbinding target cell lysis and of lymphokine-induced enhancement of human natural killer cell activity by in vitro exposure to ultraviolet B radiation. Cell Immunol 104:47-58, 1987
7. Fisher MS, Kripke ML: Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216:1133-1134, 1982
8. Gaspari AA, Fleisher TA, Kraemer KH: Impaired interferon production and natural killer cell activation in patients with skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 92:1135-1142, 1993
9. Gilmour JW, Vestey JP, George S, Norval M: Effect of phototherapy and urocanic acid isomers on natural killer cell function. J Invest Dermatol 101:169-174, 1993
10. Goettsch W, Garssen J, De Gruijl FR, Loveren H. Effects of UVB on the immune system and the consequences for the resistance against infectious diseases. In: Jung EG, Holick MF (eds). Biological Effects of Light. Berlin: Walter Degruyter, 1993, pp 637-641
11. Hersey P, Bradley M, Hasic E, Haran G, Edwards E, McCarthy WH: Immunological effects of solarium exposure in human subjects. Lancet 1:545-548, 1983a
12. Hersey P, Haran G, Hasic E et al: Alteration of T cell subsets and induction of suppressor T-cell activity in normal subject after exposure to sunlight. J Immunol 131:171-174, 1983b
13. Hersey P, MacDonald M, Henderson C, Schibeci S, D'Alessandro G, Pryor M, Wilkinson FJ: Suppression of natural killer cell activity in humans by radiation from solarium lamps depleted of UVB. J Invest Dermatol 90:305-310, 1988
14. Koren HS, Leung KH: Modulation of human NK cells by interferon and prostaglandin E2. Mol Immunol 19:1341-1346, 1982
15. Kripke ML: Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev 80:87-102, 1984
16. Laerum O, Iversen OH (eds): The Biology of Skin Cancer. Geneva: UICC Technical Report Series, Vol. 63, 1981
17. Liu Y, Wei SHY, Ho ASY et al: Expression cloning and characterization of human IL-10 receptor. J Immunol 152:1821-1829, 1994
18. Mariani E, Facchini A, Honorati MC, et al: Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin Exp Immunol 88:376-382, 1992
19. Miyauchi Hashimoto H, Tanaka K, Horio T: Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol 107:343-348, 1996
20. Morison WL, Parrish JA, Block KJ et al: In vivo effect of UVB on lymphocyte function. Br J Dermatol 101:513-519, 1979
21. Morison WL, Bucana C, Hashem N, Kripke ML, Cleaver JE, German JL: Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 45:3929-3931, 1985
22. Moscicki RA, Morison WL, Parrish JA et al: Reduction of the function of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psolaren/ultraviolet-A radiation (PUVA). J Invest Dermatol 79:205-208, 1982
23. Nakane H, Takeuchi S, Yuba S, et al: High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumors in mice lacking the xeroderma pigmentosum group A gene. Nature 377:165-168, 1995
24. Nishigori C, Yarosh DB, Ullrich SE, Vink AA, Bucana CD, Roza L, Kripke ML: Evidence that DNA damage triggers IL 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci USA 93:10354-10359, 1996
25. Norris PG, Limb GA, Hamblin AS, Hawk JLM: Impairment of natural-killer cell activity in xeroderma pigmentosum. N Engl J Med 319:1668-1669, 1988
26. Norris PG, Limb GA, Hamblin AS, et al: Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J Invest Dermatol 94:94-100, 1990
27. Ortaldo JR, Longo DL: Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness. J Natl Cancer Inst 80:999-1010, 1988
28. Ortaldo JR, Lang NP, Timonen T, Herberman RB: Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of effector cells. J Interferon Res 1:253-262, 1981
29. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG: Xeroderma pigmentosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasmas, and abnormal DNA repair. Ann Intern Med 80:221-248, 1974
30. Schacter B, Lederman MM, Le Vine MJ, Ellner JJ: Ultraviolet radiation inhibits human natural killer cell activity and lymphocyte proliferation. J Immunol 130:2484-2487, 1983
31. Toda K, Miyachi Y, Nesumi N, Konishi J, Imamura S: UVB/PUVA-induced suppression of human natural killer activity is reduced by superoxide dismutase and/or interleukin 2 in vitro. J Invest Dermatol 86:519-522, 1986
32. Ullrich SE: The role of epidermal cytokines in the generation of cutaneous immune reactions and ultraviolet radiation-induced immune suppression. Photochem Photobiol 62:389-401, 1995
33. Vose BM. Natural killers in human cancer: activity of tumor-infiltrating and draining node lymphocytes. In: Heberman RB (ed.). Natural Cell Mediated Immunity Against Tumors. New York: Academic Press, 1980, pp 1081-1087
34. Weitzen ML, Bonavida B: Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J Immunol 133:3128-3132, 1984
35. Wysenbeek AJ, Weiss H, Duczyminer-Kahana M, Grunwald MH, Pick AI: Immunologic alterations in xeroderma pigmentosum patients. Cancer 58:219-221, 1986